|
JARID2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.56030000031393E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.17049761181465E-11 |
| Normal-vs-Stage2 |
8.276000E-03 |
| Normal-vs-Stage3 |
7.87670000000906E-05 |
| Normal-vs-Stage4 |
1.045710E-02 |
| Stage1-vs-Stage2 |
6.409200E-01 |
| Stage1-vs-Stage3 |
1.777850E-02 |
| Stage1-vs-Stage4 |
2.389600E-02 |
| Stage2-vs-Stage3 |
5.004200E-01 |
| Stage2-vs-Stage4 |
3.637800E-01 |
| Stage3-vs-Stage4 |
6.361800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.3330999595409E-09 |
| Normal-vs-AfricanAmerican |
2.615000E-04 |
| Normal-vs-Asian |
5.002500E-03 |
| Caucasian-vs-AfricanAmerican |
1.886770E-01 |
| Caucasian-vs-Asian |
6.536400E-01 |
| AfricanAmerican-vs-Asian |
8.544600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.69780000011966E-07 |
| Normal-vs-Female |
5.58500024006037E-10 |
| Male-vs-Female |
2.056000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.050450E-02 |
| Normal-vs-Age(41-60Yrs) |
2.44630005141744E-09 |
| Normal-vs-Age(61-80Yrs) |
1.19919999996831E-06 |
| Normal-vs-Age(81-100Yrs) |
2.886200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.121800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.628370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.841800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.731600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.391800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.240200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.571450E-04 |
| Normal-vs-Grade 2 |
7.17269577066304E-11 |
| Normal-vs-Grade 3 |
3.63560000000707E-05 |
| Normal-vs-Grade 4 |
1.631990E-02 |
| Grade 1-vs-Grade 2 |
5.955900E-02 |
| Grade 1-vs-Grade 3 |
1.836740E-04 |
| Grade 1-vs-Grade 4 |
2.980800E-04 |
| Grade 2-vs-Grade 3 |
1.816680E-03 |
| Grade 2-vs-Grade 4 |
2.581000E-03 |
| Grade 3-vs-Grade 4 |
4.462200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.04494232447905E-12 |
| Normal-vs-ccB subtype |
2.361000E-04 |
| ccA subtype-vs-ccB subtype |
6.562500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.36569999975578E-07 |
| Normal-vs-N1 |
4.646400E-01 |
| N0-vs-N1 |
2.380600E-01 |
|
|
